News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Aditxt, Inc.
< Previous
1
2
Next >
Aditxt Retains Riverside Management Group as Advisor to Support Strategic M&A Driven Acquisitions by Subsidiary Pearsanta, Inc.
March 03, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Forms its Second Subsidiary, Pearsanta, Inc., to Accelerate the Growth of its AditxtScore™ Program and Appoints Healthcare Executive and Current Head of AditxtScore™ Anthony Voorhies to Serve as its President
February 14, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Forms Adimune, Inc. as a Wholly Owned Subsidiary with a Focus on Immune Modulation Therapies and Appoints Dr. Friedrich Kapp, Former President of the Therapeutic Business Unit at Schering AG, as its Chairman and CEO
January 03, 2023
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt’s (Nasdaq: ADTX) Adimune™ Program Has Initiated the Manufacturing Process of Immunotherapeutic Drug Candidate, ADI™-100 in Preparation for Planned Psoriasis First-in-Human Trials
October 21, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc. (Nasdaq: ADTX) Announces Development and Publication of a Mathematical Model for Predicting Longevity and Variations of Immune Response to Immunization to SARS-CoV-2 Infection
October 12, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
FedEx Features AditxtScore™ Immune Monitoring Center and its Service in Richmond, VA, Highlighting the Importance of Quantifying Immune Health
October 07, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc. (NASDAQ: ADTX) Announces That it Has Regained Compliance with Nasdaq Listing Requirements
September 29, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Inc. (Nasdaq: ADTX) Provides Corporate Highlights Post Reverse Stock Split and Closing of $20M Public Offering
September 27, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Announces Closing of $20.0 Million Public Offering
September 20, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc. (Nasdaq: ADTX) Announces 1-for-50 Reverse Stock Split Effective Pre-Market Opening on September 14, 2022
September 13, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc. Successfully Completes Preclinical Toxicity Study of Its Psoriasis Drug Candidate ADI™-100 Advancing it Closer to First-in-Human Trials
July 08, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc. Partners with Guthy-Renker Affiliate GRS to Launch Consumer Awareness Campaign for AditxtScore™ to Accelerate Adoption and Revenue Growth
April 14, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Signs Revenue-Sharing Agreement with Cellvera for up to $30M, and Hosts a Live Business Update Webinar on April 14th
April 05, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt to Participate in the 2022 Virtual Growth Conference
March 23, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Submits Two Requests for Emergency Use Authorization to FDA for AditxtScore™ for COVID-19 Tests Which Measure the Quantity and Quality of Antibodies Against COVID-19 and its Variants Including Omicron
January 18, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc. to Participate in Edison Group’s Global Healthcare “Open House” Virtual Conference From January 25th-27th, 2022
January 14, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Provides Online Business Update Townhall Meeting with Amro Albanna, Co-Founder & CEO
January 12, 2022
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Signs Amendment to Extend Worldwide Licensing Agreement, Granting Exclusivity in all Fields of Use
December 29, 2021
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt, Inc. Signs Non-Binding Letter of Intent to Acquire Point-of-Care Diagnostic Technology Development Company
December 13, 2021
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Announces Closing of $17.4 Million Firm Commitment Public Offering of Common Stock and Warrants
December 06, 2021
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Extends the Timeline to Sign the Definitive Agreement to Acquire AiPharma Global to December 16, 2021
December 02, 2021
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Announces Pricing of $17.4 Million Firm Commitment Public Offering of Common Stock and Warrants Led by Leading Healthcare Investor
December 01, 2021
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Announces Proposed Public Offering of Common Stock and Warrants
November 30, 2021
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
The Largest Law Enforcement Agency in the State of Kansas, Johnson County Sherriff’s Office, to Become First in the Nation to Deploy AditxtScore™ for Immune Scoring for its Employees and First Responders
November 22, 2021
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Webinar at 2pm ET to Explore PRESECO Results
November 12, 2021
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Provides an Update Regarding its Target Acquisition AiPharma Global Holdings LLC
November 12, 2021
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Partners With CLX Health to Offer AditxtScore™ for COVID-19 Immune Monitoring Service Through CLX’s TrustAssure™ Platform
November 03, 2021
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Announces Closing of $4.25 Million Public Offering
October 20, 2021
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt to Present at the Dawson James 6th Annual Small Cap Growth Conference in Florida on October 21, 2021
October 20, 2021
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
Aditxt Announces Pricing of $4.25 Million Public Offering
October 18, 2021
From
Aditxt, Inc.
Via
Business Wire
Tickers
ADTX
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.